Send feedback

FA2H p.Arg235Cys

c.703C>T · rs387907039 · VCV30870

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 6 submitters
AlphaMissense
ambiguous
0.4235 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00133%, afr)
Missense predictors
2/2 damaging
REVEL, SaProt · AlphaMissense indeterminate
Conditions
2
hereditary spastic paraplegia 35

Computational evidence

Protein change
AlphaMissense0.4235ambiguous
REVEL0.845moderately pathogenic-leaning
SaProtLLR -14.55damaging
⇒ REVEL and SaProt both call this damaging; AlphaMissense is indeterminate.
Splicing
SpliceAI<0.2all four deltas below 0.2 · G>T here scores Δ0.30 · evaluated, not missing
Constraint at this position
ConservationphyloP 12GERP 1.8, phastCons 1
Regional constrainto/e 0.99unconstrained · MANE · 61 kb · p 0.86 · regional, not allelic
Overall
CADD34.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00133% African / African-American · 1/74,936 alleles
Filtering AF 0.0005% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000366%
Overall 0.000867% 14/1,613,916 alleles · very rare exomes 12/1,461,712 · genomes 2/152,204 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,602
African / African-Americangrpmax 0.00133% 74,936
South Asian 0.0011% 91,088
European (non-Finnish) 0.000932% 107,276

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
FA2H
Protein
p.Arg235Cys
Coding
c.703C>T
MANE Select
NM_024306
dbSNP
rs387907039
Type
single nucleotide variant
Location
chr16:74719071 (GRCh38)
Gene constraint
LOEUF 0.759 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 85.53
Residue 235
a UniProt-annotated variant site (in spg35; significantly reduced enzymatic function); the fatty acid hydroxylase domain
Full FA2H gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary spastic paraplegia 35 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: intellectual disability

For Autosomal recessive spastic paraplegia type 35 (Orphanet):

Inheritance
Autosomal recessive
Onset
Adolescent, Childhood

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/fa2h-p-arg235cys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown